52 research outputs found
Statistics Norway from cell offices to open landscape. A survey from Department of Administration
The Statistics Norway (SN) office relocation survey was conducted from February
4th to 15th, 2013 and covered all administration department employees who
regularly work in Oslo. The survey aimed at investigating employees’ satisfaction
with the current physical environment of the office and their preferences to open
and cell offices. The total number of respondents was 62 of which 42 returned the
questionnaires. The survey shows that a majority of the administration staff were
satisfied with the current physical environment of the office and their preference is
towards cell office design. Key findings include:
Almost half of the respondents travel between 30 and 59 minutes to reach the
office from where they stay
65 percent of the respondents arrive at office before 08:30 am to have enough
concentration, to get off early from work and to avoid traffic during normal
hours
95 percent of the respondents agreed that they can communicate effectively in
the current offices
75 percent of the respondents do not consider their job to be rather unpleasant
More females believe that open offices encourages communication
27 percent of the respondents agreed that closed offices limit knowledge sharing
and 24 percent were not sure
87 percent of the respondents preferred cell office to other types of office design
61 percent of the respondents do not know the type of office they will occupy
after relocation
51 percent of the respondents were neutral on their satisfaction with the role of
the trade unions in the preparation of office relocation
39 percent of the respondents disagreed that they are looking forward to
working in the new offices
42 percent were not looking forward to working at the new location
58 percent of the respondents were aged 50 and above
More than 60 percent of the respondents have been working at SN for 10 or
more year
Antibiotic prophylaxis for ophthalmia neonatorum in Italy: results from a national survey and the Italian intersociety new position statements
Background: Ophthalmia neonatorum is an acute conjunctivitis that occurs in newborns within the first month of life. The most serious infections are due to Chlamydia trachomatis and Neisseria gonorrhoeae, that may cause permanent damages. The use of ophthalmic prophylaxis varies widely around the world, according to the different health and socio-economic contexts. To date in Italy there is no a clear legislation regarding ophthalmia neonatorum prophylaxis at birth. Methods: We invited all birth centers in Italy to carry out a retrospective survey relating the last three years. We collected data regarding demographics of neonates, drugs used for ophthalmic prophylaxis and results of the screening of pregnant women for Chlamydia trachomatis and Neisseria gonorrhoeae vaginal infections. Results: Among 419 birth centers, 302 (72,1%) responded to the survey. Overall 1041384 neonates, 82,3% of those born in the three years considered, received ophthalmic prophylaxis. Only 4,585 (0,4%) of them received one of the drugs recommended by the WHO. The Centers that participated to the survey reported 12 episodes of Chlamydial conjunctivitis and no Gonococcal infection in the three years. Only 38% of the Centers performed vaginal swabs to pregnant women: 2,6% screened only for Neisseria, 9,6% only for Chlamydia and 25,8% for both germs. Conclusions: The data obtained from the survey showed a low incidence of neonatal conjunctivitis due to either Neisseria gonorrhoeae or Chlamydia trachomatis in Italy. Due to the lack of legislation regulating the prophylaxis of ophthalmia neonatorum in newborns, the Italian Society of Neonatology, the Italian Society of Obstetrics and Gynecology and the Italian Society of Perinatal Medicine have recently issued new recommendations on this topic
Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)
Background Among interleukin-6 inhibitors suggested for use in COVID-19, there are few robust evidences for the efficacy of sarilumab. Herein, we evaluated the efficacy and safety of sarilumab in severe COVID-19.Methods In this phase 3, open-labeled, randomized clinical trial, conducted at 5 Italian hospitals, adults with severe COVID-19 pneumonia (excluding mechanically ventilated) were randomized 2:1 to receive intravenous sarilumab (400 mg, repeatable after 12 h) plus standard of care (SOC) (arm A) or to continue SOC (arm B). Randomization was web-based. As post-hoc analyses, the participants were stratified according to baseline inflammatory parameters. The primary endpoint was analysed on the modified Intention-To-Treat population, including all the randomized patients who received any study treatment (sarilumab or SOC). It was time to clinical improvement of 2 points on a 7-points ordinal scale, from baseline to day 30. We used Kaplan Meier method and log-rank test to compare the primary outcome between two arms, and Cox regression stratified by clinical center and adjusted for severity of illness, to estimate the hazard ratio (HR). The trial was registered with EudraCT (2020-001390-76).Findings Between May 2020 and May 2021, 191 patients were assessed for eligibility, of whom, excluding nine dropouts, 176 were assigned to arm A (121) and B (55). At day 30, no significant differences in the primary endpoint were found (88% [95% CI 81-94] in arm A vs 85% [74-93], HR 1.07 [0.8-1.5] in arm B; log-rank p = 0.50). After stratifying for inflammatory parameters, arm A showed higher probability of improvement than B without statistical significance in the strata with C reactive protein (CRP) < 7 mg/dL (88% [77-96] vs 79% [63-91], HR 1.55 [0.9-2.6]; log-rank p = 0.049) and in the strata with lymphocytes <870/mmc (90% [79-96]) vs (73% [55-89], HR 1.53 [0.9-2.7]; log-rank p = 0.058). Overall, 39/121 (32%) AEs were reported in arm A and 14/55 (23%) in B (p = 0.195), while serious AEs were 22/121 (18%) and 7/55 (11%), respectively (p = 0.244). There were no treatment-related deaths.Interpretation The efficacy of sarilumab in severe COVID-19 was not demonstrated both in the overall and in the stratified for severity analysis population. Exploratory analyses suggested that subsets of patients with lower CRP values or lower lymphocyte counts might have had benefit with sarilumab treatment, but this finding would require replication in other studies. The relatively low rate of concomitant corticosteroid use, could partially explain our results.Funding This study was supported by INMI "Lazzaro Spallanzani" Ricerca Corrente Linea 1 on emerging and ree-merging infections, funded by Italian Ministry of Health.Copyright (c) 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.
BACKGROUND: Persons infected with human immunodeficiency virus (HIV) have increased rates of coronary artery disease (CAD). The relative contribution of genetic background, HIV-related factors, antiretroviral medications, and traditional risk factors to CAD has not been fully evaluated in the setting of HIV infection.
METHODS: In the general population, 23 common single-nucleotide polymorphisms (SNPs) were shown to be associated with CAD through genome-wide association analysis. Using the Metabochip, we genotyped 1875 HIV-positive, white individuals enrolled in 24 HIV observational studies, including 571 participants with a first CAD event during the 9-year study period and 1304 controls matched on sex and cohort.
RESULTS: A genetic risk score built from 23 CAD-associated SNPs contributed significantly to CAD (P = 2.9 × 10(-4)). In the final multivariable model, participants with an unfavorable genetic background (top genetic score quartile) had a CAD odds ratio (OR) of 1.47 (95% confidence interval [CI], 1.05-2.04). This effect was similar to hypertension (OR = 1.36; 95% CI, 1.06-1.73), hypercholesterolemia (OR = 1.51; 95% CI, 1.16-1.96), diabetes (OR = 1.66; 95% CI, 1.10-2.49), ≥ 1 year lopinavir exposure (OR = 1.36; 95% CI, 1.06-1.73), and current abacavir treatment (OR = 1.56; 95% CI, 1.17-2.07). The effect of the genetic risk score was additive to the effect of nongenetic CAD risk factors, and did not change after adjustment for family history of CAD.
CONCLUSIONS: In the setting of HIV infection, the effect of an unfavorable genetic background was similar to traditional CAD risk factors and certain adverse antiretroviral exposures. Genetic testing may provide prognostic information complementary to family history of CAD
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries
Background
Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres.
Methods
This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries.
Results
In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia.
Conclusion
This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries
Abstract
Background
Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres.
Methods
This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries.
Results
In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia.
Conclusion
This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries
The result of surgery for mediastinal parathyroid tumors: a comparative study of 63 patients.
Purpose: Parathyroidectomy for ectopic mediastinal hyperfunctioning glands could be performed by transcervical approach, sternotomy, thoracotomy, and recently by thoracoscopic and mediastinoscopic approaches. This study was aimed to analyze the results of traditional and video-assisted parathyroidectomy for mediastinal benign hyperfunctioning glands. Methods: Fifty-one upper mediastinal exploration by a conventional cervicotomy, 12 by video-assisted approaches (two thoracoscopy and 10 transcervical mediastinoscopy) and six by sternotomy were performed in 63 patients with primary hyperparathyroidism.
Results: Video-assisted and sternotomic parathyroid explorations achieved biochemical cure in all cases; following conventional transcervical mediastinal exploration, a persistent hyperparathyroidism occurred in 11.8% of patients, who were subsequently cured by sternotomic approach. No complications occurred after video-assisted parathyroidectomy, while an overall morbidity rate of 50% and 10% was found after sternotomic and conventional cervicotomic approaches. Postoperative pain and hospital stay were significantly increased following sternotomy; patient's subjective cosmetic satisfaction was significantly higher after video-assisted and conventional cervicotomic approaches. Conclusions: Conventional cervicotomic parathyroidectomy may achieve satisfactory results, especially for upper mediastinal glands. Sternotomic approaches are effective, but should be limited because of invasiveness and increased morbidity. In case of deep and lower hyperfunctioning mediastinal parathyroids, video-assisted approaches represent a less invasive, effective, and safe alternative and might be the technique of choice
Outcome and prognostic factors of local recurrent rectal cancer: a pooled analysis of 150 patients.
Surgery is the only curative treatment in patients with locally
recurrent rectal cancer (LRRC). The aim of this study was to evaluate the outcome
and the prognostic factors of tumour-free resection margin (R0) and overall
survival (OS) in LRRC.
METHODS: Consecutive LRRC patients observed between 1987 and 2005 in three
Italian university hospitals were evaluated. Survival curves were estimated using
the Kaplan-Meier method and compared with the log-rank test. In order to identify
factors associated with both R0 resection and OS, a logistic regression analysis
was performed in patients who underwent surgery with curative intent.
RESULTS: Out of 150 patients with LRRC, 107 underwent surgery, but since 7 were
found to have unresectable disease only 100 underwent surgical resection. Of
them, 51 underwent radical and 49 extended resection. Sixty of the 107 patients
underwent multimodality treatment. In 61 patients, R0 resection was achieved.
Median OS after surgery was 43.4 months. In patients, who had surgery with
curative intent, independent variables associated with R0 resection were: surgery
for the primary tumour performed in other hospitals (p = 0.042) extended
resection (p = 0.025) and use of positron emission tomography (PET) as a staging
modality (p = 0.03). Independent variables associated with OS were:
post-operative radiotherapy (p = 0.004), stage of the primary tumour (p = 0.004),
R0 resection (p = 0.00001), and use of PET (0.02).
CONCLUSIONS: Resection for LRRC results in improved survival. Other than the
well-known prognostic factors R0 resection and OS, PET scan has an independent
impact both on OS and R0 resection. It should therefore be included in routine
clinical practice when staging LRRC
Outcomes of Adrenalectomy in adrenal incidentalomas with subclinical Cushing's syndrome.
Purpose: Adrenalectomy represents the definitive treatment in
clinically evident Cushing's Syndrome, while the most
appropriate treatment in case of subclinical Cushing's Syndrome
(SCS) in adrenal incidentalomas remains controversial. This
study was aimed to compare the outcome of adrenalectomy or
conservative management in adrenal incidentalomas with SCS.
Methods: Twenty patients underwent laparoscopic adrenalectomy
for SCS in adrenal incidentaloma, while 15 were
managed conservatively. Hormonal laboratory parameters
of corticosteroidal secretion, arterial blood pressure (BP),
glycometabolic control parameters, and quality of life (by the
SF-36 questionnaire) were assessed pre and postoperatively.
Results: The 2 groups were equivalent concerning demographics,
preoperative laboratory data, BP levels. In the surgical
group, no postoperative morbidity occurred; laboratory corticosteroidal
parameters normalized in all patientswhile never in the
conservative group (p<0.01). In operated patients, a normalization
or significant amelioration of BP was achieved in 53% and
glucose intolerance recovered in 54% of cases; while in the
conservative group no significant ameliorations or some worsening
occurred (p<0.01). SF-36 physical and mental components
significantly ameliorated in the surgical group (p<0.01).
Conclusions: Adrenalectomy can be more beneficial than
conservative management in SCS. Surgery may achieve
remission of laboratory hormonal abnormalities, improve
BP values, glycemic control, and quality of life
- …